Literature DB >> 29707974

Mass spectrometric analysis of glycosylated viral proteins.

David J Harvey1,2.   

Abstract

INTRODUCTION: Viral diseases contribute much to human and animal suffering and enormous efforts are directed at developing appropriate vaccines for protection. Glycoproteins constitute much of the viral surfaces and are obvious targets for such vaccine development. This review describes mass spectrometric methods used for the structural determination of these compounds. Areas covered: The review describes the structures of the N- and O-linked glycans found on glycoproteins and mass spectrometric methods for their ionization and fragmentation. The steps, such as determination of glycan attachment sites and the structures of the attached glycans following their release from the glycoproteins are described and examples are given of the uses of the various analytical methods using mainly influenza, Ebola and HIV as representative examples. Also included are tables listing work on many other viruses. Expert commentary: Recent technological advances, such as the introduction of ion mobility techniques, have greatly improved analyses in this area and have enabled larger amounts of information to be gathered in shorter time periods on ever smaller amounts of material. Such techniques should greatly accelerate the discovery of vaccine targets and lead to the production of vaccines for diseases not currently available.

Entities:  

Keywords:  Ebola; Glycoprotein; N-glycan; electrospray; human immunodeficiency virus; influenza; matrix-assisted laser desorption/ionization (MALDI); site analysis

Mesh:

Substances:

Year:  2018        PMID: 29707974     DOI: 10.1080/14789450.2018.1468756

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  6 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

2.  State-of-the-Art Glycomics Technologies in Glycobiotechnology.

Authors:  Alexander Pralow; Samanta Cajic; Kathirvel Alagesan; Daniel Kolarich; Erdmann Rapp
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 3.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

Review 4.  Influenza virus N-linked glycosylation and innate immunity.

Authors:  Ian A York; James Stevens; Irina V Alymova
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

Review 5.  Mass Spectrometry-Based Structural Virology.

Authors:  Tobias P Wörner; Tatiana M Shamorkina; Joost Snijder; Albert J R Heck
Journal:  Anal Chem       Date:  2020-12-04       Impact factor: 6.986

Review 6.  Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.

Authors:  Sayantani Chatterjee; Joseph Zaia
Journal:  Mass Spectrom Rev       Date:  2022-09-29       Impact factor: 9.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.